Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 3/18/22 → 1/29/26 |
Financiación
- UCB Biopharma SRL (Belgium): 143.043,00 US$
ORAL UCB0599: A Double-blind, Placebo-Controlled, Randomized, 18-Month Phase 2A Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of Oral UCB0599 In Study Participants With Early Parkinson's Disease
- Slevin, John (PI)